ロード中...

Rituximab mediates loss of CD19 on B cells in the absence of cell death

OBJECTIVE: To evaluate loss of the B cell specific marker CD19 with addition of rituximab (RTX) to healthy donor blood and to determine the role of complement mediated cytotoxicity in these cells. METHODS: Healthy donor whole blood and peripheral blood mononuclear cells (PBMC) were evaluated for los...

詳細記述

保存先:
書誌詳細
主要な著者: Jones, Jonathan D., Hamilton, B. JoNell, Rigby, William F. C.
フォーマット: Artigo
言語:Inglês
出版事項: 2012
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3448861/
https://ncbi.nlm.nih.gov/pubmed/22674374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.34560
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!